# PureTech to Present at 9th Annual SVB Leerink Global Healthcare Conference

- Link: https://www.directorstalkinterviews.com/puretech-to-present-at-9th-annual-svb-leerink-global-healthcare-conference/412805857
- Published: 2020-02-18T07:11:08+00:00
- Author: Giles Arbor

**PureTech Health plc** (LON:PRTC) has today announced that Daphne Zohar, founder
and chief executive officer, will present at the 9th Annual SVB Leerink Global Healthcare
Conference in New York on Tuesday, 25 February at 9:00 AM EST. A webcast of the 
presentation will be available at http://puretechhealth.com/investors under the 
Reports and Presentations tab.

**About PureTech Health**

PureTech is a clinical stage biotechnology company dedicated to discovering, developing
and commercialising highly differentiated medicines for devastating diseases, including
intractable cancers, lymphatic and gastrointestinal diseases, central nervous system
disorders, and inflammatory and immunological diseases, among others. The Company
has created a broad and deep pipeline through the expertise of its experienced research
and development team and its extensive network of scientists, clinicians and industry
leaders. This pipeline, which is being advanced both internally and through PureTech’s
affiliates, is comprised of 23 product candidates and one product that has been 
cleared by the US Food and Drug Administration (FDA). All of the underlying programmes
and platforms that resulted in this pipeline of product candidates were initially
identified or discovered and then advanced by the PureTech team through key validation
points based on the Company’s unique insights into the biology of the brain, immune,
and gut, or BIG, systems and the interface between those systems, referred to as
the BIG Axis.

Share on: